====== Kali Barrett ======

{{ ::dr.-k-barrett-headshot-300x300.jpg?200|}}

Dr. **Kali Alyssa Barrett**, M.D., MSc, FRCPC is a Canadian physician based in [[canada:ontario:Toronto]], [[canada:Ontario]].

===== Education =====

Barrett received her Bachelor of Arts with a major in Art History and a minor in Health Studies at [[Queen’s University]], in Kingston, Ontario. She received her Medical degree from the [[Schulich School of Medicine and Dentistry]] at the [[University of Western Ontario]]. She completed her training in Internal Medicine and Adult Critical Care Medicine at the [[University of Toronto]]. She has a Master’s of Science in Health Policy, Planning & Financing from the [[London School of Economics & Policy]], and the [[London School of Hygiene & Tropical Medicine]], and was awarded the [[Brian Abel Smith]] award for top marks in her course work and thesis. She is currently pursuing additional training in health technology assessment at the [[Institute of Health Policy, Management and Evaluation]] at U of T.

===== Career and Affiliations =====

==== Toronto Western Hospital ====

Barrett is an attending physician at the [[Toronto Western Hospital]], part of the [[University Health Network]].((//Dr. Kali Barrett.// Critical Care. Retrieved April 29, 2022, from https://archive.ph/MSV4r))

==== University of Toronto ====

Barrett is a faculty member at the [[University of Toronto]].((//Kali Barrett.// University of Toronto. Retrieved April 29, 2022, from https://archive.ph/thSJN))

==== Health Quality Ontario ====

She serves on the Ontario Health Technology Advisory Committee at Health Quality Ontario (now part of [[Ontario Health]]), which reviews the economic and clinical evidence for health technologies and makes recommendations regarding whether they should be publicly funded in Ontario.((//Dr. Kali Barrett, Ontario COVID-19 Science Advisory Table.// Renewing Our Democratic Alliance. Retrieved May 16, 2022, from https://rodanet.org/speakers/dr-kali-barrett/))

==== Critical Care Canada Forum ====

Barrett has been a speaker at the [[Critical Care Canada Forum]], which is sponsored by [[medical_technology_companies:Masimo]], [[medical_technology_companies:Medtronic]], [[pharmaceutical_companies:Merck]], and [[pharmaceutical_companies:Paladin Labs]].((//Sponsored Webinars 2021.// Critical Care Canada Forum. Retrieved May 4, 2022, from https://archive.ph/pw8YU)) ((//Dr. Kali Barrett.// Critical Care Canada Forum. Retrieved May 16, 2022, from https://archive.ph/gTUdU))

==== Renewing Our Democratic Alliance ====

Barrett has been a panelist for [[Renewing Our Democratic Alliance]], a joint initiative between the [[Canadian International Council]] and the [[Konrad Adenauer Stiftung]] to "strengthen civil society cooperation among Canadian and German scholars, experts, and practitioners on key issues facing liberal democracies."((//Dr. Kali Barrett, Ontario COVID-19 Science Advisory Table.// Renewing Our Democratic Alliance. Retrieved May 16, 2022, from https://rodanet.org/speakers/dr-kali-barrett/))
==== Ontario COVID-19 Science Advisory Table ====

Barrett is a member of the secretariat of the [[Ontario COVID-19 Science Advisory Table]], where she acts as a senior research associate.((//About Us.// Ontario COVID-19 Science Advisory Table. Retrieved April 28, 2022, from https://covid19-sciencetable.ca/about/))

==== COVID-19 Modelling Collaborative ====

Barrett is a core member of the [[COVID-19 Modelling Collaborative]], a group of scientists and clinicians working on simulations to predict the health, health system, and economic impact of COVID-19.((//Our Team.// (2021, February 22). COVID-19 Modelling Collaborative. https://web.archive.org/web/20220429071942/https://www.covid-19-mc.ca/our-team)) The group received funding from the [[Ontario Together Fund]] (OTF), a business grant program that supports manufacturing and innovation for goods and services "critical to the health, safety, and security of Ontarians."((//Check your eligibility for the Ontario Together Fund.// COVID-19 (Coronavirus) in Ontario. Retrieved April 29, 2022, from https://web.archive.org/web/20220429072442/https://covid-19.ontario.ca/check-your-eligibility-ontario-together-fund)) ((Barrett, K. (2021). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://web.archive.org/web/20220429071445/https://covid19-sciencetable.ca/wp-content/uploads/2021/04/Declaration-of-Interest_Science-Table_Kali-Barrett_20210417.pdf))

===== Research =====

Her research is focused on the cost-effectiveness of critical care programs and delivery, as well as evidence-based policy development. She has published papers on [[H1N1]] swine flu.((Barrett, K., & Fan, E. (2015). //Reassuring Long-Term Outcomes for Australian and New Zealand Survivors of Severe Influenza A (H1N1) Infection. A Case Study in Methodological Complexity?// Annals of the American Thoracic Society, 12(6), 794–795. https://doi.org/10.1513/annalsats.201503-171ed))

==== Funding ====

Barrett disclosed personal fees from [[medical_technology_companies:Xenios]], a [[pharmaceutical_companies:Fresenius]] company, for [[COPD]]-associated research.((Barrett, K. (2021). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://web.archive.org/web/20220429071445/https://covid19-sciencetable.ca/wp-content/uploads/2021/04/Declaration-of-Interest_Science-Table_Kali-Barrett_20210417.pdf)) ((Naimark, D., Mishra, S., Barrett, K., Khan, Y. A., Mac, S., Ximenes, R., & Sander, B. (2021). //Simulation-Based Estimation of SARS-CoV-2 Infections Associated With School Closures and Community-Based Nonpharmaceutical Interventions in Ontario, Canada.// JAMA Network Open, 4(3), e213793. https://doi.org/10.1001/jamanetworkopen.2021.3793))